Intravenous Tirofiban After Delayed Thrombolysis in Stroke

Summary

A multicenter, double-blind, double-dummy, randomized trial evaluating the efficacy and safety of intravenous tirofiban in acute ischemic stroke (AIS) patients without large/medium vessel occlusion, who presented 4.5-24 hours after onset and received intravenous thrombolysis (IVT).

Timeline

Start

2025-12-01

Primary completion

2028-12-01

Completion

2029-03-01

Drugs

Indications